Oncology & Cancer
Blood test might help guide pancreatic cancer treatment
(HealthDay)—A simple blood test might help predict a pancreatic cancer patient's chances of benefiting from chemotherapy, a small study suggests.
Jan 23, 2013
0
0
Page 5 - News tagged with chemotherapy regimens
Oncology & Cancer
Understanding individual genetic variation can help predict chemotherapy side effects
The largest study ever on the effect of genetic variability on the toxicity of chemotherapy in breast cancer shows that it is possible to predict which patients are most likely to suffer serious side effects, a researcher ...
Mar 23, 2012
0
0
Oncology & Cancer
Study links Hodgkin lymphoma treatment to possible risk of stomach cancer
(Medical Xpress)—Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer ...
Aug 27, 2013
0
0
Oncology & Cancer
Trial shows positive results for lung cancer patients taking chemotherapy plus durvalumab and tremelimumab
Patients with metastatic non-small cell lung cancer (mNSCLC) who received a combined regimen of durvalumab, tremelimumab, and chemotherapy experienced a statistically significant improvement in progression-free survival and ...
Sep 9, 2021
0
0
Oncology & Cancer
E-mail prompts improve code status documentation
(HealthDay)—For patients with advanced lung cancer, prompting oncologists via e-mail successfully improved both the rate and timing of outpatient code status documentation in patients' electronic health records, according ...
Jan 5, 2013
0
0
Oncology & Cancer
When less is more: A modified chemotherapy regimen for a rare type of lymphoma
Burkitt lymphoma (BL) is a highly aggressive form of non-Hodgkin lymphoma (NHL) that comes in three different variants: endemic, immunodeficiency-associated, and sporadic. Of these variants, sporadic BL is most commonly found ...
Sep 1, 2021
0
4
Oncology & Cancer
Adding bavituximab to second-line chemotherapy doubles response rate
Adding the monoclonal antibody bavituximab to docetaxel chemotherapy doubles overall response rate and improves progression-free survival and overall survival in late-stage non-squamous, non-small cell lung cancer (NS-NSCLC) ...
Sep 6, 2012
0
0
Oncology & Cancer
The challenges of cancer vaccines
The first therapeutic cancer vaccine has now been approved by the FDA, and a diverse range of therapeutic cancer vaccines directed against a spectrum of tumor-associated antigens are currently being evaluated in clinical ...
Mar 6, 2012
0
0
Oncology & Cancer
Obesity and high weight linked to adverse outcomes in leukemia treatment
As the United States faces a growing obesity epidemic, scientists are taking a closer look at how body weight can affect health outcomes. New research published in Blood Advances highlights the potential association of elevated ...
Jul 13, 2023
0
2
Oncology & Cancer
Lymphoma trial finds combination targeted therapy effective prior to chemotherapy
Results of a Phase II clinical trial conducted at The University of Texas MD Anderson Cancer Center revealed that combination targeted therapy, consisting of rituximab, lenalidomide and ibrutinib (RLI), had an 84.6 percent ...
Jun 4, 2019
0
1
